374Water Inc. Form 10-Q Summary
Business Context and Reporting Period
374Water develops and commercializes AirSCWO supercritical water oxidation systems that process wet, hazardous and non-hazardous waste into recoverable water, energy and minerals. The unaudited interim report covers the three and nine months ended September 30, 2023, with comparisons to the corresponding 2022 periods.
- Principal product: AirSCWO waste-treatment systems; the company also provides treatability studies and related services.
- Manufacturing is outsourced primarily to Merrell Bros. Fabrication, LLC, a related party.
- As of November 9, 2023, 132,667,107 common shares were outstanding.
Financial Performance and Position
| Metric | Q3 2023 | Q3 2022 | Nine Months 2023 | Nine Months 2022 |
|---|---|---|---|---|
| Revenue | $12,290 | $922,718 | $863,611 | $2,226,477 |
| Gross profit (loss) | $(166,390) | $110,332 | $(80,471) | $263,598 |
| Operating loss | $(1,882,384) | $(912,988) | $(5,330,064) | $(3,001,583) |
| Net loss | $(1,731,431) | $(912,826) | $(5,022,351) | $(2,999,959) |
| Loss per share | $(0.01) | $(0.01) | $(0.04) | $(0.02) |
| Net cash used in operations | Not separately provided | Not separately provided | $(6,699,629) | $(2,598,193) |
- Gross margin was approximately negative 1,354% in Q3 2023 versus approximately 12% in Q3 2022; for the first nine months, it was approximately negative 9% versus approximately 12% in 2022.
- At September 30, 2023, cash was $12.8 million, total current assets were $16.8 million, current liabilities were $0.6 million and working capital was $16.3 million.
- Total assets were $18.0 million and total liabilities were $0.6 million. The filing does not report outstanding debt or borrowings.
- Inventory was $1.9 million, including $1.5 million of work-in-process. Unbilled accounts receivable increased to $1.7 million.
- Cash increased by $8.8 million during the first nine months, primarily from $13.5 million of common-stock issuance proceeds and $2.0 million from the sale of investments, partially offset by operating cash use.
Material Changes Versus the Prior Comparable Period
- Q3 revenue declined 99% year over year, and nine-month revenue declined 61%. Management attributed the decline to fewer recognized revenue milestones and the absence of completed unit sales during 2023 through the reporting date.
- Management increased estimated costs to complete a unit, adversely affecting revenue recognized in Q3 and contributing to the quarterly gross loss.
- Q3 operating expenses increased 68% to $1.7 million. Nine-month operating expenses increased 61% to $5.2 million.
- Nine-month compensation and related expenses increased 93% to $2.2 million, while general and administrative expense increased 76% to $1.8 million, primarily due to staffing, stock-based compensation and marketing.
- Research and development expense increased 30% to $0.9 million for the first nine months, primarily reflecting development of the HEC-Prime engine.
- The company sold 3,766,422 common shares under its at-the-market facility during the first nine months, generating approximately $13.41 million net of commissions and related fees. Approximately $86.56 million remained available under the facility.
- Common shares outstanding increased from 126.7 million at December 31, 2022 to 132.7 million at September 30, 2023. Potential dilution included 10.6 million options and 1.2 million warrants.
Guidance, Outlook, Commentary, Risks and Unusual Items
- No quantitative revenue, earnings or unit-sales guidance was provided. Management stated that it had promising leads from treatability studies but had not closed a unit sale during 2023 through September 30.
- Management said it was reevaluating its strategy to preserve resources given current market conditions, while continuing investments in personnel, marketing, manufacturing capabilities and HEC-Prime research and development.
- Management believes available funds will meet financial obligations and working-capital needs for at least the next 12 months from the report date, but cautioned that additional financing may be required and may not be available on commercially reasonable terms.
- Customer concentration is significant: one customer represented 96% of revenue for the nine months ended September 30, 2023. The company also relies substantially on one manufacturing vendor.
- Related-party expenses totaled $736,775 for the first nine months, with $131,923 accrued at September 30, 2023, all associated with AirSCWO manufacturing.
- The company recognized $667,950 of stock-based compensation during the first nine months.
- The company implemented a new ERP system in July 2023 and concluded that disclosure controls and internal control over financial reporting were effective as of September 30, 2023.
- Jeff Quick became Interim Chief Executive Officer on September 1, 2023, and Brad Meyers was appointed Chief Operating Officer on November 6, 2023.
- The filing reports no material legal proceedings, no defaults and no material litigation accruals.
- The revenue note contains an apparent textual inconsistency showing 2022 equipment revenue as $21,662,702, while the financial statements and MD&A show total 2022 nine-month revenue of $2,226,477 and equipment revenue of $2,162,702.
Investor Verification Checklist
- Verify the timing, probability and economics of prospective AirSCWO unit sales and whether treatability-study leads convert into orders.
- Assess the sustainability of cash resources relative to the company’s $6.7 million nine-month operating cash burn and ongoing losses.
- Review the terms, potential dilution and remaining capacity of the $100 million at-the-market equity facility.
- Evaluate customer and supplier concentration, including the dependence on one customer and Merrell Bros. for manufacturing.
- Reconcile revenue recognition estimates, milestone completion and the reported increase in estimated unit-completion costs.
- Confirm the apparent 2022 revenue disclosure inconsistency in the final filed financial statements.
- Monitor outstanding options, warrants and future stock-based compensation for additional dilution.